Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave
Ayman Al Jurdi, Leela Morená, Mariesa Cote, Emily D. Bethea, Jamil Azzi, Leonardo V. Riella
Topics & Concepts
MedicineInternal medicineCohortIncidence (geometry)Adverse effectRetrospective cohort studySolid organTransplantationGastroenterologyOrgan transplantationImmunologySurgeryOpticsPhysicsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesHepatitis C virus research